Article

Free of charge medicine schemes in the NHS. A local and regional Drug and Therapeutic Committees (DTC) experience.

2021-07-11

Abstract excerpt

<h4>Introduction: </h4> Free-of-charge (FoC) medicine schemes are increasingly available and allow access to investigational treatments outside clinical trials or in advance of licensing or NHS commissioning. <h4>Methods:</h4> We retrospectively reviewed FoC medicine schemes evaluated between 2013 and 2019 by a single NHS trust and a regional drug and therapeutics committee (DTC). The details of each locally revie...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2b9240be-d5de-563e-ba81-7acc81fcdcdb
DOI: 10.22541/au.162601445.50513844/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Free of charge medicine schemes in the NHS. A local and regional Drug and Therapeutic Committees (DTC) experience.DOI 10.22541/au.162601445.50513844/v1Read

Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible DocumentationSemantic proximity Read

Quantifying the Dual Value and Governance Risks of Early Access Programs in Oncology: A Single-Centre Analysis and National Policy FrameworkSemantic proximity Read

The costs and benefits of an early access scheme for oncology medicines in IrelandSemantic proximity Read

Prescription volume and costs of over-the-counter–like drugs in Japan by patient and healthcare facility characteristics: A nationwide descriptive studySemantic proximity Read

Compassionate use of orphan drugsSemantic proximity Read

New Mechanisms to Fund Independent Clinical Trials for Repurposing Off-Patent or Generic MedicinesSemantic proximity Read

Design and rationale for an empirical investigation of the resource use and costs of investigator-initiated randomized trials in Switzerland, the United Kingdom, and GermanySemantic proximity Read

Academic challenges on ATMPs’ development: a regulatory perspectiveSemantic proximity Read

U.S. Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Semantic proximity Read

Operationalisation of the African Medicines Agency: Retrospective evaluation of the continental centralized pilot procedure – timelines to recommendation and national registration decisionsSemantic proximity Read

Rare Diseases Clinical Trials Toolbox - Public resources and main considerations to set up a clinical trial on medicinal products for humans in EuropeSemantic proximity Read

Analysis of Patient Access to Orphan Drugs in TurkeySemantic proximity Read